United States Antipsychotic Drugs Market Report 2017

August 2017 | 100 pages | ID: UDBA07BA79AEN
QYResearch

Abstracts

In this report, the United States Antipsychotic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antipsychotic Drugs in these regions, from 2012 to 2022 (forecast).

United States Antipsychotic Drugs market competition by top manufacturers/players, with Antipsychotic Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Johnson & Johnson
• Pfizer
• Eli Lilly
• Bristol-Myers Squibb
• AstraZeneca
• GlaxoSmithKline

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Typical Antipsychotics
• Atypical Antipsychotics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antipsychotic Drugs for each application, including

• Schizophrenia
• Psychotic Depression
• Dementia
• Bipolar Disorder

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antipsychotic Drugs Market Report 2017

1 ANTIPSYCHOTIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Antipsychotic Drugs
1.2 Classification of Antipsychotic Drugs by Product Category
  1.2.1 United States Antipsychotic Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antipsychotic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Typical Antipsychotics
  1.2.4 Atypical Antipsychotics
1.3 United States Antipsychotic Drugs Market by Application/End Users
  1.3.1 United States Antipsychotic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Schizophrenia
  1.3.3 Psychotic Depression
  1.3.4 Dementia
  1.3.5 Bipolar Disorder
1.4 United States Antipsychotic Drugs Market by Region
  1.4.1 United States Antipsychotic Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antipsychotic Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Antipsychotic Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antipsychotic Drugs Status and Prospect (2012-2022)
  1.4.5 New England Antipsychotic Drugs Status and Prospect (2012-2022)
  1.4.6 The South Antipsychotic Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Antipsychotic Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antipsychotic Drugs (2012-2022)
  1.5.1 United States Antipsychotic Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Antipsychotic Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIPSYCHOTIC DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antipsychotic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antipsychotic Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antipsychotic Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Antipsychotic Drugs Market Competitive Situation and Trends
  2.4.1 United States Antipsychotic Drugs Market Concentration Rate
  2.4.2 United States Antipsychotic Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antipsychotic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIPSYCHOTIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antipsychotic Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Antipsychotic Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Antipsychotic Drugs Price by Region (2012-2017)

4 UNITED STATES ANTIPSYCHOTIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antipsychotic Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antipsychotic Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Antipsychotic Drugs Price by Type (2012-2017)
4.4 United States Antipsychotic Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIPSYCHOTIC DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antipsychotic Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Antipsychotic Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIPSYCHOTIC DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Johnson & Johnson
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antipsychotic Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Johnson & Johnson Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Antipsychotic Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.2 Antipsychotic Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bristol-Myers Squibb
  6.4.2 Antipsychotic Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bristol-Myers Squibb Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AstraZeneca
  6.5.2 Antipsychotic Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AstraZeneca Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
  6.6.2 Antipsychotic Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Antipsychotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 ANTIPSYCHOTIC DRUGS MANUFACTURING COST ANALYSIS

7.1 Antipsychotic Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antipsychotic Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antipsychotic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antipsychotic Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antipsychotic Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antipsychotic Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Antipsychotic Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Antipsychotic Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antipsychotic Drugs
Figure United States Antipsychotic Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Antipsychotic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Typical Antipsychotics Product Picture
Figure Atypical Antipsychotics Product Picture
Figure United States Antipsychotic Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Antipsychotic Drugs by Application in 2016
Figure Schizophrenia Examples
Table Key Downstream Customer in Schizophrenia
Figure Psychotic Depression Examples
Table Key Downstream Customer in Psychotic Depression
Figure Dementia Examples
Table Key Downstream Customer in Dementia
Figure Bipolar Disorder Examples
Table Key Downstream Customer in Bipolar Disorder
Figure United States Antipsychotic Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Antipsychotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antipsychotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antipsychotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antipsychotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antipsychotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antipsychotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antipsychotic Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Antipsychotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antipsychotic Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Antipsychotic Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Antipsychotic Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antipsychotic Drugs Sales Share by Players/Suppliers
Figure 2017 United States Antipsychotic Drugs Sales Share by Players/Suppliers
Figure United States Antipsychotic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antipsychotic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antipsychotic Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antipsychotic Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Antipsychotic Drugs Revenue Share by Players/Suppliers
Table United States Market Antipsychotic Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Antipsychotic Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Antipsychotic Drugs Market Share of Top 3 Players/Suppliers
Figure United States Antipsychotic Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antipsychotic Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antipsychotic Drugs Product Category
Table United States Antipsychotic Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Antipsychotic Drugs Sales Share by Region (2012-2017)
Figure United States Antipsychotic Drugs Sales Share by Region (2012-2017)
Figure United States Antipsychotic Drugs Sales Market Share by Region in 2016
Table United States Antipsychotic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antipsychotic Drugs Revenue Share by Region (2012-2017)
Figure United States Antipsychotic Drugs Revenue Market Share by Region (2012-2017)
Figure United States Antipsychotic Drugs Revenue Market Share by Region in 2016
Table United States Antipsychotic Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Antipsychotic Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Antipsychotic Drugs Sales Share by Type (2012-2017)
Figure United States Antipsychotic Drugs Sales Share by Type (2012-2017)
Figure United States Antipsychotic Drugs Sales Market Share by Type in 2016
Table United States Antipsychotic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antipsychotic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antipsychotic Drugs by Type (2012-2017)
Figure Revenue Market Share of Antipsychotic Drugs by Type in 2016
Table United States Antipsychotic Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Antipsychotic Drugs Sales Growth Rate by Type (2012-2017)
Table United States Antipsychotic Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Antipsychotic Drugs Sales Market Share by Application (2012-2017)
Figure United States Antipsychotic Drugs Sales Market Share by Application (2012-2017)
Figure United States Antipsychotic Drugs Sales Market Share by Application in 2016
Table United States Antipsychotic Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Antipsychotic Drugs Sales Growth Rate by Application (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antipsychotic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Antipsychotic Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Antipsychotic Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Antipsychotic Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antipsychotic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Antipsychotic Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Antipsychotic Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Antipsychotic Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Antipsychotic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Antipsychotic Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Antipsychotic Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly Antipsychotic Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Antipsychotic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Antipsychotic Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Antipsychotic Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Antipsychotic Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Antipsychotic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Antipsychotic Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Antipsychotic Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Antipsychotic Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antipsychotic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Antipsychotic Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Antipsychotic Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Antipsychotic Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antipsychotic Drugs
Figure Manufacturing Process Analysis of Antipsychotic Drugs
Figure Antipsychotic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antipsychotic Drugs Major Players/Suppliers in 2016
Table Major Buyers of Antipsychotic Drugs
Table Distributors/Traders List
Figure United States Antipsychotic Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Antipsychotic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antipsychotic Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Antipsychotic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antipsychotic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antipsychotic Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Antipsychotic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antipsychotic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antipsychotic Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Antipsychotic Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Antipsychotic Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antipsychotic Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antipsychotic Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources